Why Graph Topology Matters: Insights from Applications in Drug Discovery
Knowledge Graphs in Drug Discovery
Repurposing existing drugs to treat diseases beyond what they were originally designed for can be a way to identify new disease treatment opportunities. But how do we identify which drugs might affect a given disease? This and similar questions in drug discovery, which require identifying new links between known entities, can be addressed with the help of Knowledge Graphs (KGs), graph-structured repositories of information that represent facts as (head, relation, tail) triples, connecting entities head and tail with an edge that categorizes their relationship. In the biomedical domain, entities can represent drugs and diseases, but also genes, pathways, side effects, etc. KG edges represent interactions like (disease A, associates, gene B), (gene X, upregulates, gene Y) and many more.